High prevalence of p16 staining in malignant tumors

p16 (CDKN2A) is a member of the INK4 class of cell cycle inhibitors, which is often dysregulated in cancer. However, the prevalence of p16 expression in different cancer types is controversial. 15,783 samples from 124 different tumor types and 76 different normal tissue types were analyzed by immuno...

Descripción completa

Detalles Bibliográficos
Autores principales: De Wispelaere, Noémi, Rico, Sebastian Dwertmann, Bauer, Marcus, Luebke, Andreas M., Kluth, Martina, Büscheck, Franziska, Hube-Magg, Claudia, Höflmayer, Doris, Gorbokon, Natalia, Weidemann, Sören, Möller, Katharina, Fraune, Christoph, Bernreuther, Christian, Simon, Ronald, Kähler, Christian, Menz, Anne, Hinsch, Andrea, Jacobsen, Frank, Lebok, Patrick, Clauditz, Till, Sauter, Guido, Uhlig, Ria, Wilczak, Waldemar, Steurer, Stefan, Burandt, Eike, Krech, Rainer, Dum, David, Krech, Till, Marx, Andreas, Minner, Sarah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9302831/
https://www.ncbi.nlm.nih.gov/pubmed/35862385
http://dx.doi.org/10.1371/journal.pone.0262877

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9302831/
https://www.ncbi.nlm.nih.gov/pubmed/35862385
http://dx.doi.org/10.1371/journal.pone.0262877

Ejemplares similares